Inhibition of staphylococcal enterotoxin B-induced lymphocyte proliferation and tumor necrosis factor alpha secretion by MAb5, an anti- toxic shock syndrome toxin 1 monoclonal antibody

Infection and Immunity

Volumn 68, Issue 6, 2000, Pages 3261-3268

  Pang, Liwina T Y ^a,b   Kum, Winnie W S ^a,b   Chow, Anthony W ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b VANCOUVER HOSPITAL AND HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY 5; STAPHYLOCOCCUS ENTEROTOXIN B; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CROSS REACTION; LYMPHOCYTE PROLIFERATION; MITOGENESIS; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; T LYMPHOCYTE; TOXIC SHOCK SYNDROME;

ANTIBODIES, BACTERIAL; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; ANTIGEN-ANTIBODY REACTIONS; BACTERIAL TOXINS; BINDING SITES; CROSS REACTIONS; ENTEROTOXINS; EPITOPE MAPPING; HUMANS; LYMPHOCYTE ACTIVATION; MODELS, MOLECULAR; SHOCK, SEPTIC; SUPERANTIGENS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034034354     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.6.3261-3268.2000     Document Type: Article

References (39)

1. Betley, M. J., D. W. Borst, and L. B. Regassa. 1992. Staphylococcal enterotoxins, toxic shock syndrome toxin and streptococcal pyrogenic exotoxins: a comparative study of their molecular biology. Chem. Immunol. 55:1-35.
2. Bohach, G. A., D. J. Fast, R. D. Nelson, and P. M. Schlievert. 1990. Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illness. Crit. Rev. Microbiol. 17:251-272.
3. Bohach, G. A., C. J. Hovde, J. P. Handley, and P. M. Schlievert. 1988. Cross-neutralization of staphylococcal and streptococcal pyrogenic toxins by monoclonal and polyclonal antibodies. Infect. Immun. 56:400-404.
4. Borja, C. R., and M. S. Bergdoll. 1967. Purification and partial characterization of enterotoxin C produced by Staphylococcus aureus strain 137. Biochemistry 6:1467-1473.
5. Davies, H. D., A. McGeer, B. Schwartz, K. Green, D. Cann, A. E. Simor, and D. E. Low. 1996. Invasive group A streptococcal infections in Ontario, Canada. Ontario group A streptococcal study group. N. Engl. J. Med. 335:547-554.
6. Fleischer, B. 1994. Superantigens. APMIS 102:3-12 (Review).
7. Geysen, H. M., S. J. Rodda, T. J. Mason, G. Tribbick, and P. G. Schoofs. 1987. Strategies for epitope analysis using peptide synthesis. J. Immunol. Methods 102:259-274.
8. Hamad, A. R. A., A. Herman, P. Marrack, and J. W. Kappler. 1994. Monoclonal antibodies defining functional sites on the toxin superantigen staphylococcal enterotoxin B. J. Exp. Med. 180:615-621.
9. Herman, A., J. W. Kappler, P. Marrack, and A. M. Pullen. 1991. Superantigens: mechanism of T cell stimulation and role in immune responses. Annu. Rev. Immunol. 9:745-772.
10. Hynes, W. L., C. R. Weeks, J. J. Iandolo, and J. J. Ferretti. 1987. Immunologic cross-reactivity of type A streptococcal exotoxin (erythrogenic toxin) and staphylococcal enterotoxins B and C1. Infect. Immun. 55:837-838.
11. Jardetzky, T. S., J. H. Brown, J. C. Gorga, L. J. Stern, R. G. Urban, Y. I. Chi, C. Stauffacher, J. L. Strominger, and D. C. Wiley. 1994. Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen. Nature 368:711-718.
12. Jett, M., R. Neill, C. Welch, T. Boyle, E. Bernton, D. Hoover, G. Lowell, R. E. Hunt, S. Chatterjee, and P. Gemski. 1994. Identification of staphylococcal enterotoxin B sequences important for induction of lymphocyte proliferation by using synthetic peptide fragments if the toxin. Infect. Immun. 62:3408-3415.
13. Kain, K. C., M. Schulzer, and A. W. Chow. 1993. Clinical spectrum of nonmenstrual toxic shock syndrome (TSS): comparison with menstrual TSS by multivariate discriminant analyses. Clin. Infect. Dis. 16:100-106.
14. Kim, J., R. G. Urban, J. L. Strominger, and D. C. Wiley. 1994. Toxic shock syndrome toxin-1 complexed with a class II major histocompatibility molecule HLA-DR 1. Science 266:1870-1878.
15. Komisar, J. L., S. Small-Harris, and J. Tseng. 1994. Localization of binding sites of staphylococcal enterotoxin B (SEB), a superantigen, for HLA-DR by inhibition with synthetic peptides of SEB. Infect. Immun. 62:4775-4780.
16. Kotzin, B. L., D. Y. M. Leung, J. Kappler, and P. Marrack. 1993. Superantigens and their potential role in human disease. Adv. Immunol. 54:99-166.
17. Kum, W. W. S., K. B. Laupland, and A. W. Chow. 2000. Defining a novel domain of staphylococcal toxic shock syndrome toxin-1 critical for major histocompatibility complex class II binding, superantigenic activity, and lethality. Can. J. Microbiol. 46:171-179.
18. Kum, W. W. S., K. B. Laupland, R. H. See, and A. W. Chow. 1993. Improved purification and biologic activities of staphylococcal toxic shock syndrome toxin 1. J. Clin. Microbiol. 31:2654-2660.
19. Kum, W. W. S., J. A. O. Wood, and A. W. Chow. 1996. A mutation at glycine residue 31 of toxic shock syndrome toxin-1 defines a functional site critical for major histocompatibility complex class II binding and superantigenic activity. J. Infect. Dis. 174:1261-1270.
20. Li, H., A. Llera, D. Tsuchiya, L. Leder, X. Ysern, P. M. Schlievert, K. Karjalainen, and R. A. Mariuzza. 1998. Three dimensional structure of the complex between a T cell receptor beta chain and the superantigen staphylococcal enterotoxin B. Immunity 9:807-816.
21. Lokker, N. A., U. Strittmatter, C. Steiner, B. Fagg, P. Graff, H. P. Kocher, and G. Zenke. 1991. Mapping the epitopes of neutralizing anti-human IL-3 monoclonal antibodies. Implications for structure-activity relationship. J. Immunol. 146:893-898.
22. Marrack, P., and J. Kappler. 1990. The staphylococcal enterotoxins and their relatives. Science 248:705-711.
23. Meyer, R. F., E. M. MacNeill, R. W. Bennett, and J. D. MacMillan. 1984. Development of a monoclonal antibody capable of interacting with five serotypes of Staphylococcus aureus enterotoxin. Appl. Environ. Microbiol. 47:283-287.
24. Miethke, T., K. Duschek, C. Wahl, K. Heeg, and H. Wagner. 1993. Pathogenesis of the toxic shock syndrome: T cell mediated lethal shock caused by the superantigen TSST-1. Eur. J. Immunol. 23:1494-1500.
25. Minor, T. E., and E. H. Marth. 1971. Staphylococcus aureus and staphylococcal food intoxications. A review. II. Enterotoxins and epidemiology. J. Milk Food Technol. 35:21-29.
26. Papageorgiou, A. C., R. D. Brehm, D. D. Leonidas, H. S. Tranter, and K. R. Acharya. 1996. The refined crystal structure of toxic shock syndrome toxin-1 at 2.07 Å resolution. J. Mol. Biol. 160:553-569.
27. Papageorgiou, A. C., H. S. Tranter, and K. R. Acharya. 1998. Crystal structure of microbial superantigen staphylococcal enterotoxin B at 1.5Å resolution: implications for superantigen recognition by MHC class II molecules and T-cell receptors. J. Mol. Biol. 277:61-79.
28. Parsonnet, J. 1989. Mediators in the pathogenesis of TSS: overview. Rev. Infect. Dis. 11(Suppl. 1):S263-S269.
29. Reiser, R. F., R. N. Robbins, A. L. Noleto, G. P. Khoe, and M. S. Bergdoll. 1984. Identification, purification, and some physicochemical properties of staphylococcal enterotoxin C3. Infect. Immun. 45:625-630.
30. Schad, E. M., A. C. Papageorgiou, L. A. Svensson, and K. R. Acharya. 1997. A structural and functional comparison of staphylococcal enterotoxins A and C2 reveals remarkable similarity and dissimilarity. J. Mol. Biol. 269:270-280.
31. Schlievert, P. M., G. A. Bohach, D. H. Ohlendorf, C. V. Stauffacher, D. Y. Leung, D. L. Murray, G. S. Prasad, C. A. Earhart, L. M. Jablonski, M. L. Hoffmann, and Y. I. Chi. 1995. Molecular structure of staphylococcus and streptococcus superantigens. J. Clin. Immunol. 15(Suppl.):4S-10S.
32. See, R. H., and A. W. Chow. 1992. Staphylococcal toxic shock syndrome toxin 1-induced tumor necrosis factor alpha and interleukin-1b secretion by human peripheral blood monocytes and T lymphocytes is differentially suppressed by protein kinase inhibitors. Infect. Immun. 60:3456-3459.
33. Shimonkevitz, R., E. Boen, S. Malmstrom, E. Brown, J. M. Hurley, B. L. Kotzin, and M. Matsumura. 1996. Delineation by use of specific monoclonal antibodies of the T-cell receptor and major histocompatibility complex interaction sites on the superantigen toxic shock syndrome toxin 1. Infect. Immun. 64:1133-1139.
34. Shinagawa, K., T. Kanazawa, N. Matsusaka, S. Sugii, and S. Nagata. 1991. Murine monoclonal antibodies reactive with staphylococcal enterotoxins A, B, C2, D, E. FEMS Microbiol. Lett. 64:35-39.
35. Soos, J. M., J. K. Russell, M. A. Jarpe, C. H. Pontzer, and H. M. Johnson. 1993. Identification of binding domains on the superantigen, toxic shock syndrome-1, for class II MHC molecules. Biochem. Biophys. Res. Commun. 191:1211-1217.
36. 2+-mediated homodimerization. EMBO J. 15:6832-6840.
37. Swaminathan, S., W. Furey, J. Pletcher, and M. Sax. 1992. Crystal structure of staphylococcal enterotoxin B, a superantigen. Nature 359:801-806.
38. Tranter, H. S., R. D. Brehm, and K. R. Acharya. 1995. Molecular topology is important for the function of staphylococcal superantigens, p. 5-23. In J. Thibodeau and R. Sekaly (ed.), Bacterial superantigens: structure, function and therapeutic potential. Springer-Verlag, Heidelberg, Germany.
39. Ulrich, R. G., M. A. Olson, and S. Bavari. 1998. Development of engineered vaccines effective against structurally related bacterial superantigens. Vaccine 16:1857-1864.